產(chǎn)品詳情
簡(jiǎn)單介紹:
AT56
詳情介紹:
Purpose | A selective, competitive, and highly bioavailable inhibitor of L-PGDS (lipocalin-type prostaglandin D synthase) |
Characteristics | AT-56 is a selective, competitive, and highly bioavailable inhibitor of L-PGDS (lipocalin-type prostaglandin D synthase) (Ki = 75 μM). It inhibits the production of PGD2 by L-PGDS purified from human CSF and recombinant mouse cells with an IC?? value of 95 μM. At concentrations as high as 100 μM in vitro or 30 mg/kg in vivo, AT-56 does not affect the production of PGE2, PGF2α, or H-PGDS-catalyzed PGD2. PubChem CID: 11741525 |
Purity | ≥ 98?% by HPLC |
Chemical Name | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine |
Formula | C??H??N? |
Permeability | Cell-permeable |
Solubility | DMSO (>15 mg/ml) |
Molecular Weight | 397.52 g/mol |
CAS-No | 162640-98-4 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from light and air |
Storage | -20 °C |
Expiry Date | 36 months |
Supplier Images |
|